22nd Century Group Makes Big Investment in Hemp-Derived CBD

22nd Century Group Makes Big Investment in Hemp-Derived CBD

22nd Century Group (XXII), a plant biotechnology company that focuses on tobacco harm reduction, very low nicotine content tobacco and hemp/cannabis plant research, is...
- Advertisement -